...
首页> 外文期刊>American Journal of Veterinary Research >Evaluation of the use of atropine sulfate, a combination of butylscopolammonium bromide and metamizole sodium, and flunixin meglumine to ameliorate clinical adverse effects of imidocarb dipropionate in horses.
【24h】

Evaluation of the use of atropine sulfate, a combination of butylscopolammonium bromide and metamizole sodium, and flunixin meglumine to ameliorate clinical adverse effects of imidocarb dipropionate in horses.

机译:评估使用硫酸阿托品,溴化丁基sco碱铵和间苯二甲酸钠的组合以及氟尼辛葡甲胺改善马来酸咪唑威二丙酸酯的临床不良反应。

获取原文
获取原文并翻译 | 示例
           

摘要

Objective - To evaluate the ability of atropine sulfate, butylscopolammonium bromide combined with metamizole sodium, and flunixin meglumine to ameliorate the clinical adverse effects of imidocarb dipropionate in horses. Animals - 28 horses with piroplasmosis. Procedures - 28 horses were randomly assigned to 4 equal groups according to the pretreatment administered. Fifteen minutes before administration of 2.4 mg of imidocarb dipropionate/kg IM, horses in the first group were pretreated with 0.02 mg of atropine sulfate/kg IV, the second group with a combination of 0.2 mg of butylscopolammonium bromide/kg IV and 25 mg of metamizole sodium/kg IV, the third group with 1.1 mg of flunixin meglumine/kg IV, and the fourth (control) group with 1 mL of saline (0.9% NaCl) solution/50 kg IV. Physical examination, including evaluation of rectal temperature, heart and respiratory rates, capillary refill time, mucous membrane color, hydration status, abdominal sounds, signs of abdominal pain, salivation, diarrhea, and number of defecations, was performed. Results - Imidocarb dipropionate use in the control group was associated with serious adverse effects including signs of abdominal pain (4/7 horses) and diarrhea (2/7). Horses pretreated with atropine had no diarrhea, but 6 had signs of abdominal pain. Only 1 horse that received butylscopolammonium-metamizole pretreatment had signs of abdominal pain and 3 had diarrhea, which was numerically but not significantly different than the control group. Of horses pretreated with flunixin, 3 had signs of abdominal pain and 3 had diarrhea. Conclusions and Clinical Relevance - A combination of butylscopolammonium bromide and metamizole sodium may be useful to ameliorate the adverse effects of imidocarb dipropionate in horses, although group size was small and significant differences from the control group were not found.
机译:目的-评价硫酸阿托品,溴化丁基sco碱铵,间苯二甲酸钠和氟尼辛葡甲胺改善马来酸咪唑威二丙酸酯的临床不良反应的能力。动物-患有疟原虫的28匹马。程序-根据所进行的预处理将28匹马随机分为4组。在给予2.4 mg丙咪唑碳二丙酸酯/ kg IM的前15分钟,第一组马用0.02 mg硫酸阿托品/ kg IV预处理,第二组马用0.2 mg丁基丁基0.2草铵/ kg IV和25 mg灭蚁灵钠/ kg静脉注射,第三组用1.1 mg氟尼辛葡甲胺/ kg静脉注射,第四组(对照组)用1 mL盐水(0.9%NaCl)溶液/ 50 kg静脉注射。进行了身体检查,包括评估直肠温度,心脏和呼吸频率,毛细血管补充时间,粘膜颜色,水合状况,腹部声音,腹痛迹象,流涎,腹泻和排便次数。结果-对照组使用丙二酸亚氨基甲酸与严重的不良反应有关,包括腹痛(4/7马)和腹泻(2/7)的迹象。用阿托品预处理的马没有腹泻,但有6腹痛的迹象。只有1匹接受丁基sco草铵-甲咪唑预处理的马有腹痛的征兆,而3匹有腹泻的征象,虽然在数值上与对照组无明显差异,但差异无统计学意义。经氟尼辛预处理的马中,有3人有腹痛的迹象,有3人有腹泻的迹象。结论和临床意义-丁基scopolmonmonium溴化物和间苯二甲酸钠的组合可能有助于缓解马丙酸咪唑威酯对马的不利影响,尽管组的规模很小并且未发现与对照组的显着差异。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号